SHORT MINI FUTURE WARRANT - MERCK & CO. | Real-time BOERSE MUENCHEN 17:25:44 05/06/2024 BST | ||
| 1.45 EUR | -1.36% |
|
| Current month | -19.67% | ||
| 1 month | -6.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/06/24 | 1.45 | -1.36% |
| 04/06/24 | 1.47 | -6.37% |
| 03/06/24 | 1.57 | -14.21% |
| 31/05/24 | 1.83 | +12.27% |
| 30/05/24 | 1.63 | -8.43% |
Real-time BOERSE MUENCHEN
Last update June 05, 2024 at 05:25 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG6CEF |
| ISIN | DE000GG6CEF9 |
| Date issued | 02/04/2024 |
| Strike | 144.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.88 € |
|---|---|
| Lowest since issue | 1.16 € |
| Spread | 0.01 € |
| Spread % | 0.70% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7
USD
Average target price
142.7
USD
Spread / Average Target
+10.86%
- Stock Market
- Certificates
- Certificat
